潘玟伃(Pan, Wen-Yu) 助理教授

Email
wenyupan@tmu.edu.tw
現   職
醫學檢驗暨生物技術學系 助理教授

學經歷

學 歷

畢業學校與學位[修業時間]
國立陽明大學生化暨分子生物研究所博士班 博士
2005/09~2012/06
國立臺灣大學醫事技術學系碩士班 碩士
2001/09~2003/06
國立臺灣大學醫事技術學系 學士
1997/09~2001/06

本校學術經歷

任職單位與職稱[起迄時間]
醫學檢驗暨生物技術學系助理教授
2020/08/01~

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
醫學生物科技博士學位學程助理教授
2020/10/01 ~

其它經歷

任職單位與職稱[起迄時間]
國立清華大學博士後研究員
2015/08/01~2020/07/31
台中榮民總醫院博士後研究員
2014/01/13~2015/07/31
中央研究院博士後研究員
2012/08/01~2013/02/28
中央研究院研究助理
2003/08/01~2005/08/31

專長與研究領域

學門領域
學術專長

論文著作

清冊下載


1. 2024 Ngo TLH,Wang KL,Pan WY,Ruan T,Lin YJ. Immunomodulatory prodrug micelles imitate mild heat effects to reshape tumor microenvironment for enhanced cancer immunotherapy . ACS nano .2024 ;(18):5632-5646

2. 2024 Wu SH,Rethi L,Pan WY,Nguyen HT,Chuang AEY. Emerging horizons and prospects of polysaccharide-constructed gels in the realm of wound healing. . Colloids and Surfaces B: Biointerfaces .2024 ;(235):113759

3. 2023 Chen YT,Liu CH,Pan WY,Jheng PR,Hsieh YSY,Burnouf T, Fan YJ, Chiang CC, Chen TY, and Chuang EY. Biomimetic platelet nanomotors for site-specific thrombolysis and ischemic injury alleviation . ACS Applied Materials & Interfaces .2023 ;(15):32967-32983

4. 2022 Lekshmi Rethi,Chinmaya Mutalik,Lekha Rethi,Wei-Hung Chiang,Hsin-Lun Lee,Wen-Yu Pan, Tze-Sen Yang, Jeng-Fong Chiou, Yin-Ju Chen, Er-Yuan Chuang*, Long-Sheng Lu*. Molecularly Targeted Photothermal Ablation of Epidermal Growth Factor Receptor-Expressing Cancer Cells with a Polypyrrole-Iron Oxide-Afatinib Nanocomposite . Cancers .2022

5. 2021 Chen PM,Pan WY,Luo PK,Phung HN,Liu YM,Chiang MC,Chang WA,Tien TL,Huang CY,Wu WW,Chia WT,Sung HW. Pollen-mimetic metal-organic frameworks with tunable spike-like nanostructures that promote cell interactions to improve antigen-specific humoral immunity . ACS Nano .2021 ;(15):7596-7607

6. 2020 Chen PM,Pan WY,Miao YB,Liu YM,Luo PK,Phung HN,Wu WW,Ting YH,Yeh CY,Chiang MC,Chia WT,Sung HW. Bioinspired engineering of a bacterium-like metal–organic framework for cancer immunotherapy . Advanced Functional Materials .2020 ;(30)

7. 2020 Chen PM,Pan WY,Wu CY,Yeh CY,Korupalli C,Luo PK,Chou CJ,Chia WT,Sung HW. Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination . Biomaterials .2020 ;(230)

8. 2019 Miao YB,Pan WY,Chen KH,Wei HJ,Mi FL,Lu MY,Chang Y,Sung HW. Engineering a nanoscale Al-MOF-armored antigen carried by a “Trojan Horse”-like platform for oral vaccination to induce potent and long-lasting immunity . Advanced Functional Materials .2019 ;(29)

9. 2019 Korupalli C,Pan WY,Yeh CY,Chen PM,Mi FL,Tsai HW,Chang Y,Wei HJ,Sung HW. Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells in situ to elicit potent and long-lasting humoral immune responses . Biomaterials .2019 ;(216)

10. 2018 Lin WC,Pan WY,Liu CK,Huang WX,Song HL,Chang KS,Li MJ,Sung HW. In situ self-spray coating system that can uniformly disperse a poorly water-soluble H2S donor on the colorectal surface to treat inflammatory bowel diseases . Biomaterials .2018 ;(182):289-298

11. 2017 Korupalli C,Huang CC,Lin WC,Pan WY,Lin PY,Wan WL,Li MJ,Chang Y, Sung HW. Acidity-triggered charge-convertible nanoparticles that can cause bacterium-specific aggregation in situ to enhance photothermal ablation of focal infection . Biomaterials .2017 ;(116):1-9

12. 2016 Huang CC,Liao ZX,Lu HM,Pan WY,Wan WL,Chen CC,Sung HW. Cellular organelle-dependent cytotoxicity of iron oxide nanoparticles and its implications for cancer diagnosis and treatment: a mechanistic investigation . Chemistry of Materials .2016 ;(28):9017-9025

13. 2016 Huang CC,Pan WY,Tseng MT,Lin KJ,Yang YP,Tsai HW,Hwang SM,Chang Y,Wei HJ,Sung HW. Enhancement of cell adhesion, retention, and survival of HUVEC/cbMSC aggregates that are transplanted in ischemic tissues by concurrent delivery of an antioxidant for therapeutic angiogenesis . Biomaterials .2016 ;(74):53-63

14. 2016 Pan WY,Lin KJ,Huang CC,Chiang WL,Lin YJ,Lin WC,Chuang EY,Chang Y,Sung HW. Localized sequence-specific release of a chemopreventive agent and an anticancer drug in a time-controllable manner to enhance therapeutic efficacy . Biomaterials .2016 ;(101):241-250

15. 2016 Pan WY,Huang CC,Lin TT,Hu HY,Lin WC,Li MJ,Sung HW. Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites . Nanomedicine: Nanotechnology, Biology, and Medicine .2016 ;(12):431-438

16. 2015 Huang CC,Wei HJ,Lin KJ,Lin WW,Wang CW,Pan WY,Hwang SM,Chang Y,Sung HW. Multimodality noninvasive imaging for assessing therapeutic effects of exogenously transplanted cell aggregates capable of angiogenesis on acute myocardial infarction . Biomaterials .2015 ;(73):12-22

17. 2012 Pan WY,Lo CH,Chen CC,Wu PY,Roffler SR,Shyue SK,Tao MH. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains . Molecular Therapy .2012 ;(20):927-937

18. 2011 Huang YH,Fang CC,Tsuneyama K,Chou HY,Pan WY,Shih YM,Wu PY,Chen Y,Leung PSC,Gershwin ME,Tao MH. A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery . International Journal of Oncology .2011 ;(39):1511-1519

19. 2010 Lo CH,Chang CM,Tang SW,Pan WY,Fang CC,Chen Y,Wu PY,Chen KY,Ma HI,Xiao X,Tao MH. Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma . Journal of Gene Medicine .2010 ;(12):423-434

20. 2010 Chou HY,Lin XZ,Pan WY,Wu PY,Chang CM,Lin TY,Shen HH,Tao MH. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells . Journal of Immunology .2010 ;(185):5468-5475

21. 2003 Lo CH,Lee SC,Wu PY,Pan WY,Su J,Cheng CW,Roffler SR,Chiang BL,Lee CN,Wu CW,Tao MH. Antitumor and antimetastatic activity of IL-23 . Journal of Immunology .2003 ;(171):600-607

研究計畫

計畫名稱
113 裝載二甲雙胍與包覆類鐸受體7/8促進劑之奈米粒子之水膠用於活化腫瘤微環境中之T淋巴細胞與骨髓性細胞以達到抗腫瘤之功效(1/3)
補助單位
國家科學及技術委員會

計畫名稱
112 裝載GM-CSF及標靶奈米粒子疫苗之水膠複合系統用於原位募集並活化樹突細胞以增強腫瘤特異性免疫反應達到抑制癌症轉移之功效(3/3)
補助單位
國家科學及技術委員會

計畫名稱
111 裝載GM-CSF及標靶奈米粒子疫苗之水膠複合系統用於原位募集並活化樹突細胞以增強腫瘤特異性免疫反應達到抑制癌症轉移之功效(2/3)
補助單位
國家科學及技術委員會

計畫名稱
110 裝載GM-CSF及標靶奈米粒子疫苗之水膠複合系統用於原位募集並活化樹突細胞以增強腫瘤特異性免疫反應達到抑制癌症轉移之功效(1/3)
補助單位
科技部

計畫名稱
109 新聘教師研究補助
補助單位
臺北醫學大學

計畫名稱
109 開發ㄧ奈米粒子水膠複合系統作為手術後的DNA疫苗以預防癌症之復發
補助單位
科技部